‘The device that helps to comply with insulin treatment’
Since we won the III Edition 2016-17 G5 Innovation Prize for the social enterprise of the Group5, we have had several interviews this week in different media. One of the most important appearances is the one published by the leading economic newspaper in Spain, Cinco Días.
In the article you can read that our device will reach Spanish pharmacies this summer. Explain the features and benefits of Insulclock. It tells how our project was developed with the figure of our CEO as the main protagonist. It reports on our future projects, supports and possible alliances.
As always, we would like to thank our collaborating entities. They have made it possible for our work to continue: Vodafone Spain Foundation, IE Business School, Enisa, CDTI Center for Industrial Technological Development, Telefónica Open Future, Pascual Quality, Group 5, etc.
We are grateful and delighted. Winning this award has caused a great impact that has had an impact on the media. All of this helps us to continue growing and to continue working to improve the quality of life of people with diabetes.
We also want to highlight our interviews in Artesfera of RNE, La Vanguardia, LaInformación.es and Corresponsables. All different but with a common key point. Our vision. To improve the quality of life of type 1 and 2 chronic insulin dependent patients and their relatives. To expand nationally and internationally, within a sustainable and social model. How? Creating adherence to the treatment, avoiding errors, everything with our Insulclock.
We leave all the links so you can access the information.
Una mención más que se suma a la ya larga lista de Insulclock. Ya para finalizar os dejamos el enlace de la entrevista en RNE para el programa Artesfera. (La entrevista comienza a partir del minuto 18).